Canada Markets open in 8 hrs 48 mins

OncoCyte Corporation (OCX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.40000.0000 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.4000
Open3.4200
Bid0.0000 x 1100
Ask0.0000 x 1100
Day's Range3.2600 - 3.4400
52 Week Range1.4100 - 6.5700
Volume277,877
Avg. Volume604,798
Market Cap305.553M
Beta (5Y Monthly)1.91
PE Ratio (TTM)N/A
EPS (TTM)-0.3700
Earnings DateNov. 10, 2021 - Nov. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.67
  • GlobeNewswire

    Oncocyte to Report Third Quarter 2021 Financial Results on Tuesday, November 9th

    IRVINE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that it will release its financial and operating results for the third quarter ended September 30, 2021, on Tuesday, November 9, 2021, after the close of the U.S. financial markets. The Compan

  • Simply Wall St.

    A OncoCyte Corporation (NASDAQ:OCX) insider increased their holdings by 11% last year

    From what we can see, insiders were net buyers in OncoCyte Corporation's ( NASDAQ:OCX ) during the past 12 months. That...

  • GlobeNewswire

    Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer

    IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced the appointment of Gisela A. Paulsen, MPharm, to the role of Chief Operating Officer (COO). Paulsen brings with her over two decades of experience as a cross-functional leader, with an extensi